All Episodes

Managing Toxicities of EGFR Inhibitors in Lung Cancer – Drs. Azam Farooqui & Joshua Sabari

How to Treat Metastatic NSCLC with Targetable Mutations – Treatment Algorithm with Dr. Eric Singhi

How to Treat Metastatic NSCLC W/O Targeted Mutations – Treatment Algorithm with Dr. Christine Garcia

How to Treat Localized Non-Small Cell Lung cancer – Treatment Algorithm with Dr. Sanjay Popat

How to Treat Small Cell Lung Cancer (SCLC) – Treatment Algorithm with Dr. Jacob Sands

Managing Toxicities of Colorectal Cancer Drugs / Systemic Therapy – Dr. Rona Yaeger

BREAKWATER Study for BRAF V600E Mutated Colorectal Cancer – Encorafenib + Cetuximab + Chemotherapy

How to Treat Colorectal Cancer – Treatment Algorithm with Dr. Smitha Krishnamurthi

How to Treat Pancreatic Cancer – Treatment Algorithm with Dr. Shubham Pant

How to Treat Biliary Tract Cancer – Treatment Algorithm with Dr. Suneel Kamath

How to Treat Cancer of Unknown Primary (CUP) Origin – Drs. Harry Fuentes & Thor Halfdanarson

How to Treat Bladder Cancer – Drs. Stephanie Berg (Medical Oncologist) & Joshua Meeks (Urologist)

Open Evidence as an Artificial Intelligence (AI) Tool in the World of Medicine

How to Treat Renal Cell Carcinoma (RCC) in 2026 – Dr. Katy Beckermann

Evolving Treatment Landscape of HER2+ Upper GI Cancer

How to Treat Prostate Cancer Localized to Advanced Settings - Dr. Scott Tagawa

Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer

GU ASCO 2026 Highlights – CREST, POTOMAC, EV-304/KEYNOTE-B15, LITESPARK-011/022, CAPITELLO-281

Clinical Insights: Evolving Landscape of Bladder Cancer After GU ASCO 2026

Teclistamab-Daratumumab FDA Approval of MajesTEC-3 for R/R Multiple Myeloma (MM): Dr. Luciano Costa

Triple Negative Breast Cancer (TNBC) Treatment Algorithm: Dr. Tiffany Traina

Combination Approaches in PD-L1–Positive Metastatic Triple Negative Breast Cancer

HER2+ Breast Cancer Treatment Algorithm: Dr. Virginia Kaklamani

Metastatic Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Kevin Kalinsky

Early Stage Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Erica Mayer

Current & Future Role of Anktiva (N-803): Dr. Patrick Soon-Shiong

Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv HER2 Breast Cancer: DESTINY-Breast09

Navigating Acute Myeloid Leukemia Treatment: Therapy-Related & De Novo AML with Dr. Naval Daver

Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun

FDA Approval of Daratumumab in High Risk Smoldering Myeloma: AQUILA by Dr. Vincent Rajkumar

ASH 2025 Multiple Myeloma Highlights – AQUILA, COBRA, TecLILLE, MajesTEC-3: Dr. Ben Derman

GI ASCO 2026 Highlights MATTERHORN, HERIZON-GEA-01, BREAKWATER, COMMIT – Dr. Rachna Shroff

ASH 2025 Lymphoma Highlights - EPCORE FL-1, CLL-17, BRUIN CLL-313, SWOG-1826: Dr. Julie Vose

ASH 2025 Leukemia Highlights PARADIGM, KOMET-007, ASC4FIRST, ASC2ESCALATE - Dr. Jorge Cortes

HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein

Triple Negative Breast Cancer SABCS 2025 Highlights: Dr. Rebecca Shatsky

Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles

Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope Rugo

Early HR+ Disease SABCS 2025 Practice Changing/Informing Highlights: ALTTO, lidERA, NATALEE

Advancements and Challenges in Metastatic Colorectal Cancer Treatment

Clinical Implications of Testing HER2 and Targeted Therapies Approved - Dr. Komal Jhaveri

Toxicity Management of HER2+ Treatment Options in Upper GI Cancers – Drs. Geoffrey Ku & Shruti Patel

Current Treatment Landscape of Advanced Gastric/Esophageal/GEJ Adenocarcinoma – Dr. Rutika Mehta

Managing Toxicities of Antibody Drug Conjugates (ADCs) in Lung Cancer – Dr. Jacob Sands

Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar

Challenging Cases of Iron Abnormalities, Anemia or Iron Overload - Dr. Marina Beltrami

FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles

Challenging Cases in Second Line & Beyond Renal Cell Carcinoma (RCC) - Dr. David Braun

FDA Approval of Durvalumab with FLOT in Resectable Gastric & GEJ: MATTERHORN by Dr. Yelena Janjigian

Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky

Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks

FDA Approval of Ziftomenib (KOMET-001) in NPM1 mut Acute Myeloid Leukemia (AML) – Dr. Eunice Wang

Managing Toxicities of ROS1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC) – Dr. Estela Rodriguez

Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad

Lung Cancer ESMO 2025 Highlights: MDT-BRIDGE, FLAURA2, SOHO-01, Beamion LUNG-1

GI Cancer ESMO 2025 Highlights: DYNAMIC-III, PEGASUS, STELLAR-303, MATTERHORN, FORTITUDE-101

Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION

Current Treatment Landscape of Ovarian Cancer with Dr. Sharyn Lewin

GU Cancer ESMO 2025 Highlights: PSMAddition, Capitello-281, Potomac, Keynote-905, IMVigor011

Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi

Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff

Treating and Managing Chronic Myeloid Leukemia (CML) in 2025: Dr. Jorge Cortes

How to Manage Thrombocytopenia (ITP, HIT, DIC, TTP) - Dr. Ronak Mistry

IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)

Exploring the role of targeted radiopharmaceutical treatment in NETs

Challenging Cases of Venous Thromboembolism (VTE) - Drs. Jennifer Vaughn & Nicolas Gallastegui

How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid

Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson

WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos

Treating and Managing Chronic Lymphocytic Leukemia (CLL) in 2025: Dr. Mazyar Shadman

Managing Side Effects of New Treatments for Small Cell Lung Cancer

FDA Approval of Zongertinib for HER2 Mutated Non-Small Cell Lung Cancer (NSCLC) - Dr. Joshua Sabari

Latest Clinical Data for First-line Maintenance and R/R Small-Cell Lung Cancer (SCLC)

FDA Approval of Datopotamab deruxtecan (Dato-DXd) in EGFR Mutated Lung Cancer - Dr. Jacob Sands

Diagnosis and Treatment of Myelofibrosis with Dr. Raajit Rampal: Testing, Treatment, Supportive care

Managing Toxicities of TKIs and HIF-2 inhibitor in Renal Cell Carcinoma (RCC)

Myeloproliferative Neoplasms (MPN) Treatment: Polycythema Vera (PV) & Essential Thrombocythemia (ET)

Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer

Challenging Cases with Relapsed/Refractory FLT3+ Acute Myeloid Leukemia (AML)

Treating Acute Myeloid Leukemia in 2025 - Induction, Consolidation, Transplant, Target Therapies

Challenging Cases with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025

How to Treat Early Stage Non-Small Cell Lung Cancer in 2025

ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA

FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial

ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04

ASCO 2025 - GI Cancer Highlights: DYNAMIC III, ATOMIC, BREAKWATER, MATTERHORN, DESTINY Gastric04

ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304

Nivolumab plus Ipilimumab in Microsatellite-Instability–High (MSI-H) Metastatic Colorectal Cancer

Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib

How to treat Small Cell Lung Cancer in 2025

Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations

How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations

Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Treatment Options for HER2 Positive Biliary Tract Cancers

The HER2 Diagnostic and Treatment Landscape in NSCLC

Overview of Biliary Tract Cancer & Importance of Targeted Therapies

What does it mean to be HER2 Positive in Lung Cancer

European Lung Cancer Conference (ELCC) 2025 Highlights: KEYNOTE-799, LAURA, MARIPOSA, KRYSTAL-7

FDA Approval of Cabozantinib - CABINET in pNET and epNET

How to Manage & Treat Pancreatic Cancer

How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm

ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment

Prostate Cancer Management from Early Stage to Advanced Metastatic Disease - Dr. Alan Bryce

How to Treat Renal Cell Carcinoma (RCC) using a Treatment Algorithm with Dr. Katy Beckermann

How to Treat Bladder Cancer in 2025 with Dr. Joaquim Bellmunt

FDA Approval of Tislelizumab - RATIONALE 305 and 306 in Upper GI Cancers

GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2

How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025

FDA Approval of Zolbetuximab SPOTLIGHT / GLOW study - Upper GI Cancer with Claudin 18.2 Mutation

How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons

How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani

GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET

FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo

Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches

Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab

ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka

SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney

SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham

Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies

SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA

Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski

FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant

ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy

CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy

Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens

2nd line treatment in advanced HCC and when to switch

From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer

The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)

INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer

How to Approach and Treat Pancreatic Cancer

Understanding the Impact of Nutrition & Exercise on Cancer Outcomes

How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)

Palliative Care Management in Cancer

How to Approach to Ovarian Cancer from Community Oncology Perspective

How to Approach to Endometrial Cancer from Community Oncology Perspective

DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)

AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer

Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC

AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)

How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective

GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2

GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02

Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12

WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment

How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes

How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka

How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo

How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner

Role of Cardiology in Cancer Treatment: Cardio-Oncology

How to Treat Early Stage Non-Small Cell Lung Cancer

How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul

How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos

How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi

GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton

Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari

Multidisciplinary Approach for Rectal Cancer - Discussion with Dr. Deb Schrag & Dr. Krishan Jethwa

Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman

How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju

Understanding Disparities in Colorectal Cancer Care

Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi

Liver Directed Therapies - Interventional Radiology & Radiation Oncologist Perspective

Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello

Discussion on Evolving CLL Treatment Strategies with Dr. Nitin Jain

FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer

Standard of Care Treatment for Upper GI Cancer: A Discussion with Dr. Sam klempner

Standard of Care Treatment for Colon Cancer: A Discussion with Dr. Aparna Parikh

Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab

Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles

Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand

Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm

How to treat Prostate Cancer in 2024 with Dr. Rana McKay

Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study

How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers

GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564

How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein

GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2

How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss

ASH 2023 Leukemia/MDS/Myelofibrosis Highlights – TRANSFORM-1, MANIFEST-2, SAVE, AUGMENT-101 with Dr. Uma Borate

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01

ASH 2023 CLL/Lymphoma Highlights – ALPINE, SEQUOIA, SWOG-S1826, POLARIX Update with Dr. Mazyar Shadman

ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3 Update with Dr. Jens Hillengass

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

How to Treat Myelodysplastic Syndrome (MDS) with Dr. Amer Zeidan

ESMO 2023 GI Cancer Highlights – Codebreak300, CABINET, GASTFOX

ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431

ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc Brothers

ESMO 2023 GU Cancer Highlights – SunRISE-1, EV-302, PSMAfore

ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology Brothers

How to Treat Cutaneous Melanoma - Deep Dive with Dr. Sapna Patel

2023 World Conference on Lung Cancer Highlights | Dr. Stephen Liu | Oncology Brothers #2023

How to Treat Chronic Lymphocytic Leukemia (CLL) with Dr. Jeff Sharman

Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin's Lymphoma

Story of Hope by a Determined Lung Cancer Survivor - Jill Feldman

EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab

How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar

How to Treat Multiple Myeloma with Dr. Jens Hillengass

Critical Updates in Kidney, Prostate, and Bladder Cancer from ASCO 2023 with Dr. Toni Choueiri

GI Cancer ASCO 2023 Highlights with Dr. Muhammad Shaalan Beg

Lung Cancer ASCO 2023 Highlights with Dr. Charu Aggarwal

Breast Cancer ASCO 2023 Highlights with Dr. Stephanie Graff

EMERALD Ph III Study in discussion w/ Dr. Virginia Kaklamani (now FDA Approved)

Colon Cancer Algorithm Discussion with Dr. Cathy Eng

American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology

HR+ Breast Cancer Management with Dr. Margaret Gatti-Mays

HR+ Invasive Lobular Carcinoma Management with Dr. Jason Mouabbi

HER2+ Breast Cancer Algorithm Discussion with Dr. Paolo Tarantino

Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations - Dr. Jarushka Naidoo

Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/o Targetable Mutations - Dr. Eric Singhi

Localized Non-Small Cell Lung Cancer (NSCLC) Algorithm with Dr. Charu Aggarwal

Small Cell Lung Cancer (SCLC) Algorithm with Dr. Estelamari Rodriguez

MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer)

GU ASCO 2023 Highlights with Dr. Petros Grivas

Prostate Cancer Algorithm with Dr. Neeraj Agarwal

EMERALD Ph III Study in discussion w/ Dr. Aditya Bardia (now FDA Approved)

GI ASCO 2023 Highlights with Dr. Mark Lewis

The NICHE-2 Study Discussion with Dr. Myriam Chalabi

Bladder Cell Cancer Algorithm Discussion with Dr. Andrea Apolo

Kidney / Renal Cell Cancer Algorithm Discussion with Dr. Elizabeth Plimack

DESTINY-Breast04 Study Discussion with Dr. Shanu Modi

TNBC SABCS 2022 Highlights with Dr. Maryam Lustberg

ASH 2022 Highlights with Dr. Aaron Goodman "Papa Heme"

HER2+ SABCS 2022 Highlights with Dr. Erika Hamilton

HR+ SABCS 2022 Highlights with Dr. Stephanie Graff

CDK4/6i in HR+ SABCS 2022 Highlights with Dr. Sara Tolaney

Upper Gastrointestinal (GI) Cancer Algorithm with Dr. Rutika Mehta

Triple Negative Breast Cancer (TNBC) Algorithm with Dr. Shipra Gandhi

HER2-positive Breast Cancer Algorithm with Dr. Erika Hamilton

Hormone Positive Breast Cancer Algorithm with Dr. Stephanie Graff

Melanoma ESMO 2022 Highlights with Dr. Sapna Patel

Lung Cancer ESMO 2022 Highlights with Dr. Joshua Reuss

Breast Cancer ESMO 2022 Highlights with Dr. Maryam Lustberg

GI Cancer ESMO 2022 Highlights with Dr. Rachna Shroff

Genitourinary Cancer ESMO 2022 Highlights with Dr. Toni Choueiri

Introduction: @OncBrothers - Drs. Rohit and Rahul Gosain, and their mission